← All organizations

Roussel-Uclaf

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

First marketed drug

First NDA

Last known activity

Sep 19, 1996

Acquired by Hoechst → Hoechst Marion Roussel → Aventis → Sanofi-Synthelabo → Sanofi-Aventis on Jan 1, 1972

Timeline

1910s

Jan 1, 1911
Roussel-Uclaf— Founded

1970s

Jan 1, 1972
Hoechst— Acquired By

1990s

Sep 19, 1996
nilutamide— NDA Organization

2000s

Jan 1, 2004
Sanofi-Aventis— Now

Indications

Approved for

Prostatic Neoplasms

Marketed drugs (1)

nilutamide

Details

Founded: Romainville, FR Jan 1, 1911
First NDA: Sep 19, 1996
Last known activity: Sep 19, 1996